Authors:
BEAUFORT TM
NIGROVIC V
PROOST JH
HOUWERTJES MC
WIERDA JMKH
Citation: Tm. Beaufort et al., INHIBITION OF THE ENZYMATIC DEGRADATION OF SUXAMETHONIUM AND MIVACURIUM INCREASES THE ONSET TIME OF SUBMAXIMAL NEUROMUSCULAR BLOCK, Anesthesiology, 89(3), 1998, pp. 707-714
Authors:
SCHIERE S
VANDENBROEK L
PROOST JH
MOLENBUUR B
WIERDA JMKH
Citation: S. Schiere et al., COMPARISON OF VECURONIUM WITH ORG-9487 AND THEIR INTERACTION, Canadian journal of anaesthesia, 44(11), 1997, pp. 1138-1143
Citation: M. Kansanaho et al., DOSE-RESPONSE AND CONCENTRATION-RESPONSE RELATION OF ROCURONIUM INFUSION DURING PROPOFOL NITROUS-OXIDE AND ISOFLURANE NITROUS-OXIDE ANESTHESIA, European journal of anaesthesiology, 14(5), 1997, pp. 488-494
Citation: Jh. Proost et al., RELATIONSHIP BETWEEN CHEMICAL-STRUCTURE AND PHYSICOCHEMICAL PROPERTIES OF SERIES OF BULKY ORGANIC CATIONS AND THEIR HEPATIC-UPTAKE AND BILIARY-EXCRETION RATES, The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 715-726
Authors:
WIERDA JMKH
MERETOJA OA
TAIVAINEN T
PROOST JH
Citation: Jmkh. Wierda et al., PHARMACOKINETICS AND PHARMACOKINETIC-DYNAMIC MODELING OF ROCURONIUM IN INFANTS AND CHILDREN, British Journal of Anaesthesia, 78(6), 1997, pp. 690-695
Citation: Jmkh. Wierda et al., CARDIOVASCULAR EFFECTS OF AN INTUBATING DOSE OF ROCURONIUM 0.6 MG KG(-1) IN ANESTHETIZED PATIENTS, PARALYZED WITH VECURONIUM, British Journal of Anaesthesia, 78(5), 1997, pp. 586-587
Citation: Hj. Sparr et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF ROCURONIUM IN INTENSIVE-CAREPATIENTS, British Journal of Anaesthesia, 78(3), 1997, pp. 267-273
Citation: S. Schiere et al., PHARMACOKINETICS AND PHARMACOKINETIC PHARMACODYNAMIC (PK/PD) RELATIONSHIP OF ORG-9488, THE 3-DESACETYL METABOLITE OF ORG-9487/, Anesthesiology, 87(3), 1997, pp. 377-377
Citation: Jh. Proost et al., AN EXTENDED PHARMACOKINETIC PHARMACODYNAMIC MODEL DESCRIBING QUANTITATIVELY THE INFLUENCE OF PLASMA-PROTEIN BINDING, TISSUE BINDING, AND RECEPTOR-BINDING ON THE POTENCY AND TIME-COURSE OF ACTION OF DRUGS/, Journal of pharmacokinetics and biopharmaceutics, 24(1), 1996, pp. 45-77
Authors:
BEAUFORT AM
NIGROVIC V
PROOST JH
WIERDA JMKH
Citation: Am. Beaufort et al., ONSET TIME OF NEUROMUSCULAR BLOCK IS DETERMINED BY THE PHARMACOKINETICS OF THE BLOCKING DRUG, British Journal of Anaesthesia, 76(4), 1996, pp. 580-580
Citation: Ep. Mccoy et al., PHARMACOKINETICS OF ROCURONIUM AFTER BOLUS AND CONTINUOUS-INFUSION DURING HALOTHANE ANESTHESIA, British Journal of Anaesthesia, 76(1), 1996, pp. 29-33
Authors:
VANDENBROEK L
HOMMES FDM
NAP HJA
WIERDA JMKH
Citation: L. Vandenbroek et al., ROCURONIUM-INDUCED AND MIVACURIUM-INDUCED NEUROMUSCULAR BLOCK AND INTUBATING CONDITIONS - A COMPARISON WITH VECURONIUM, European journal of anaesthesiology, 12, 1995, pp. 27-30
Authors:
COOPER RA
MIRAKHUR RK
WIERDA JMKH
MADDINENI VR
Citation: Ra. Cooper et al., PHARMACOKINETICS OF ROCURONIUM BROMIDE IN PATIENTS WITH AND WITHOUT RENAL-FAILURE, European journal of anaesthesiology, 12, 1995, pp. 43-44
Citation: Jmkh. Wierda et Jh. Proost, STRUCTURE-PHARMACODYNAMIC-PHARMACOKINETIC RELATIONSHIPS OF STEROIDAL NEUROMUSCULAR BLOCKING-AGENTS, European journal of anaesthesiology, 12, 1995, pp. 45-54
Authors:
SMEULERS NJ
WIERDA JMKH
VANDENBROEK L
HUET RCGG
HENNIS PJ
Citation: Nj. Smeulers et al., HYPOTHERMIC CARDIOPULMONARY BYPASS INFLUENCES THE CONCENTRATION-RESPONSE RELATIONSHIP AND THE BIODISPOSITION OF ROCURONIUM, European journal of anaesthesiology, 12, 1995, pp. 91-94
Authors:
BEAUFORT AM
WIERDA JMKH
BELOPAVLOVIC M
NEDERVEEN PJ
KLEEF UW
AGOSTON S
Citation: Am. Beaufort et al., THE INFLUENCE OF HYPOTHERMIA (SURFACE COOLING) ON THE TIME-COURSE OF ACTION AND ON THE PHARMACOKINETICS OF ROCURONIUM IN HUMANS, European journal of anaesthesiology, 12, 1995, pp. 95-106
Authors:
PLAUD B
PROOST JH
WIERDA JMKH
BARRE J
DEBAENE B
MEISTELMAN C
Citation: B. Plaud et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ROCURONIUM AT THE VOCAL CORDS AND THE ADDUCTOR POLLICIS IN HUMANS, Clinical pharmacology and therapeutics, 58(2), 1995, pp. 185-191
Authors:
WIERDA JMKH
HOMMES FDM
NAP HJA
VANDENBROEK L
Citation: Jmkh. Wierda et al., TIME-COURSE OF ACTION AND INTUBATING CONDITIONS FOLLOWING VECURONIUM,ROCURONIUM AND MIVACURIUM, Anaesthesia, 50(5), 1995, pp. 393-396
Citation: L. Vandenbroek et al., CLINICAL-PHARMACOLOGY OF ROCURONIUM (ORG-9426) - STUDY OF THE TIME-COURSE OF ACTION, DOSE REQUIREMENT, REVERSIBILITY, AND PHARMACOKINETICS, Journal of clinical anesthesia, 6(4), 1994, pp. 288-296
Citation: Ejl. Roland et al., PHARMACODYNAMIC BEHAVIOR OF VECURONIUM IN PRIMARY HYPERPARATHYROIDISM, Canadian journal of anaesthesia, 41(8), 1994, pp. 694-698
Authors:
WIERDA JMKH
BEAUFORT AM
KLEEF UW
SMEULERS NJ
AGOSTON S
Citation: Jmkh. Wierda et al., PRELIMINARY INVESTIGATIONS OF THE CLINICAL-PHARMACOLOGY OF 3 SHORT-ACTING NONDEPOLARIZING NEUROMUSCULAR BLOCKING-AGENTS, ORG 9453, ORG 9489AND ORG 9487, Canadian journal of anaesthesia, 41(3), 1994, pp. 213-220
Authors:
WIERDA JMKH
PROOST JH
SCHIERE S
HOMMES FDM
Citation: Jmkh. Wierda et al., PHARMACOKINETICS AND PHARMACOKINETIC DYNAMIC RELATIONSHIP OF ROCURONIUM BROMIDE IN HUMANS, European journal of anaesthesiology, 1994, pp. 66-74